Notably, upregulated EGF and amphiregulin are associated with poor prognosis in NSCLC including malignant metastasis and resistance to targeted inhibitors as part of an intricate autocrine EGFR growth loop [57,60,61]. Here, AREG is linked to non-small cell lung carcinoma.